Answers are grounded in this paper and cite their sources.
Epistaxis is bleeding originating from the nostrils, nasal cavity, or nasopharynx, and affects nearly 60% of the general population at least once during their lifetime. The aim of this review is to analyze specific aspects of epistaxis associated with very high blood pressure. The need for dual management, involving both emergency/cardiologic assessment and ear, nose, and throat treatment, represents a specific feature of epistaxis associated with very high blood pressure. A lack of agreement among hypertension guidelines regarding the classification of epistaxis is evident, with some guidelines classifying it as a hypertensive emergency (HTN-E) and others as a hypertensive urgency (HTN-U). Furthermore, therapy recommended for very high blood pressure associated with epistaxis is seldom specified. This uncertainty supports a cautious approach to diuretic use. In addition, epistaxis may be challenging to manage in the subsequent days because blood pressure changes during this period are difficult to predict. From a practical perspective, it seems appropriate to treat the majority of patients with high blood pressure and epistaxis as having HTN-U, since epistaxis is rarely life-threatening and typically does not require hospitalization.
No takes yet. Share an insight, caveat, or question.
Koracevic et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: